Whole genome sequencing in oncology: using scenario drafting to explore future developments

被引：0
|
作者：
Michiel van de Ven
Martijn J. H. G. Simons
Hendrik Koffijberg
Manuela A. Joore
Maarten J. IJzerman
Valesca P. Retèl
Wim H. van Harten
机构：
[1] University of Twente,Technical Medical Centre
[2] Maastricht University Medical Center,University of Melbourne Centre for Cancer Research
[3] Maastricht University,undefined
[4] Care and Public Health Research Institute (CAPHRI),undefined
[5] University of Melbourne,undefined
[6] Peter MacCallum Cancer Centre,undefined
[7] Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL),undefined
[8] Rijnstate General Hospital,undefined
来源：
BMC Cancer | / 21卷
关键词：
Whole genome sequencing; Implementation; Scenario drafting; Uncertainty; Oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Whole genome sequencing in oncology: using scenario drafting to explore future developments
    van de Ven, Michiel
    Simons, Martijn J. H. G.
    Koffijberg, Hendrik
    Joore, Manuela A.
    IJzerman, Maarten J.
    Retel, Valesca P.
    van Harten, Wim H.
    BMC CANCER, 2021, 21 (01)
  • [2] A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology
    Kramer, Astrid
    Rubio-Alarcon, Carmen
    van den Broek, Daan
    Vessies, Daan C. L.
    van't Erve, Iris
    Meijer, Gerrit A.
    Vink, Geraldine R.
    Schuuring, Ed
    Fijneman, Remond J. A.
    Coupe, Veerle M. H.
    Retel, Valesca P.
    MOLECULAR ONCOLOGY, 2024, 18 (11) : 2730 - 2742
  • [3] A Scenario-drafting Study To Explore Potential Future Implementation Pathways Of CtDNA Testing In Oncology
    Kramer, Astrid
    Alarcon, Carmen Rubio
    Van den Broek, Daan
    Vessies, Daan C. L.
    Van't Erve, Iris
    Meijer, Gerrit A.
    Vink, Geraldine R.
    Schuuring, Ed
    Fijneman, Remond J. A.
    Coupe, Veerle M. H.
    Retel, Valesca P.
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP176 - NP178
  • [4] Scenario drafting to anticipate future developments in technology assessment
    Valesca P Retèl
    Manuela A Joore
    Sabine C Linn
    Emiel JT Rutgers
    Wim H van Harten
    BMC Research Notes, 5 (1)
  • [5] Early technology assessment of using whole genome sequencing in personalized oncology
    Simons, Martijn
    van de Ven, Michiel
    Coupe, Veerle
    Joore, Manuela
    IJzerman, Maarten
    Koffijberg, Erik
    Frederix, Geert
    Uyl -De Groot, Carin
    Cuppen, Edwin
    Van Harten, Wim
    Retel, Valesca
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (03) : 343 - 351
  • [6] Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer
    Simons, Martijn J. H. G.
    Uyl-de Groot, Carin A.
    Retel, Valesca P.
    Mankor, Joanne M.
    Ramaekers, Bram L. T.
    Joore, Manuela A.
    van Harten, Wim H.
    VALUE IN HEALTH, 2023, 26 (01) : 71 - 80
  • [7] Clinical utility of whole-genome sequencing in precision oncology
    Rosenquist, Richard
    Cuppen, Edwin
    Buettner, Reinhard
    Caldas, Carlos
    Dreau, Helene
    Elemento, Olivier
    Frederix, Geert
    Grimmond, Sean
    Haferlach, Torsten
    Jobanputra, Vaidehi
    Meggendorfer, Manja
    Mullighan, Charles G.
    Wordsworth, Sarah
    Schuh, Anna
    SEMINARS IN CANCER BIOLOGY, 2022, 84 : 32 - 39
  • [8] The Benefits of Whole-Genome Sequencing Now and in the Future
    Khromykh, Alina
    Solomon, Benjamin D.
    MOLECULAR SYNDROMOLOGY, 2015, 6 (03) : 108 - 109
  • [9] Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients
    Vu, Martin
    Degeling, Koen
    Westerman, David
    IJzerman, Maarten J.
    JOURNAL OF CANCER POLICY, 2024, 41
  • [10] Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology
    Jobanputra, Vaidehi
    Wrzeszczynski, Kazimierz O.
    Buttner, Reinhard
    Caldas, Carlos
    Cuppen, Edwin
    Grimmond, Sean
    Haferlach, Torsten
    Mullighan, Charles
    Schuh, Anna
    Elemento, Olivier
    SEMINARS IN CANCER BIOLOGY, 2022, 84 : 23 - 31
12345